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Abstract
Background—A low level of response to alcohol during an individual’s early experience with
alcohol is associated with an increase risk for alcoholism. A family-based genome-wide linkage
analysis using sibling pairs that underwent an alcohol challenge where the level of response to
alcohol was measured with the Subjective High Assessment Scale (SHAS) implicated the 10q
terminal region. CYP2E1, a gene known for its involvement with ethanol metabolism, maps to this
region.
Methods—Variance component multipoint linkage analysis was performed on a combined map
of single nucleotide polymorphism (SNP) and microsatellite data. To account for the heterogeneity
evident in the dataset, a calculation assuming locus heterogeneity was made using the HLOD
(heterogeneity LOD) score. Association between SNP marker allele counts and copy number and
SHAS scores were evaluated using a logistic regression model.
Results—Linkage analysis detected significant linkage to CYP2E1 which was diminished due to
apparent locus heterogeneity traced to a single family with extreme phenotypes. In retrospect,
circumstances recorded during testing for this family suggest that their phenotype data are likely to
be unreliable. Significant allelic associations were detected for several CYP2E1 polymorphisms
and the SHAS score. DNA sequencing from families that contributed the greatest evidence for
linkage did not detect any changes directly affecting the primary amino acid sequence. With the
removal of a single family, combined evidence from microsatellites and SNPs offer significant
linkage between the level of response to alcohol and the region on the end of chromosome 10.
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Conclusion—Combined linkage and association indicate that sequence changes in or near
CYP2E1 affect the level of response to alcohol providing a predictor of risk for alcoholism. The
absence of coding sequence changes indicates that regulatory sequences are responsible.
Implicating CYP2E1 in the level of response to alcohol allows inferences to be made about how
the brain perceives alcohol.
Keywords
level of response to alcohol; linkage analysis; association analysis; combined linkage and
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Introduction
While a number of phenotypic factors can affect the risk for alcoholism, one of the most
studied endophenotypes is an individual’s level of response to alcohol during their early
experience with alcohol (Heath et al., 1999). The level of response to alcohol can be reliably
measured with the Subjective High Assessment Scale (SHAS) during an alcohol challenge
or by the Self-Rating of the Effects of Alcohol (SRE) which uses recall to establish the
number of drinks required to reach an effect. Children of alcoholics have a greater risk for
alcoholism when they have a lower level of response (Pollock, 1992; Schuckit et al., 2000;
Schuckit and Smith, 1996). A low level of response established early in an individual’s
drinking career can lead to higher future drinking levels (Ehlers et al., 1999; Heath et al.,
1999; Volavka et al., 1996). Populations at historically higher risk for alcoholism, such as
Native American or Korean, need to consume larger amounts of alcohol to become
intoxicated (Garcia-Andrade et al., 1997; Luczak et al., 2002; Wall et al., 1999) compared to
those with lower risk (Monteiro et al., 1991) who exhibit a more intense level of response to
alcohol. Several studies have implicated genes showing association with the level of
response to alcohol (GABA, 5-HT, and KCNMA1) (Barr et al., 2003; Dick et al., 2006;
Schuckit et al., 2005). The evidence proving association for these genes is weak by current
standards that have been developed as a consequence from the technological advances
enabling genome-wide association studies. Even though these genes may affect the level of
response to alcohol to some degree, it is possible that these reported associations reflect the
typical reporting bias seen in candidate gene studies.
Initially, data were collected from 139 sibling pairs (Wilhelmsen et al., 2003). Variance
component analysis found a significant LOD (Log of Odds) score peak of 3.2 for the SHAS
score at the 10q terminal region. Of the genes located at 10qter, CYP2E1 has a known
involvement with ethanol metabolism. The CYP2E1 enzyme metabolizes ethanol and
acetaminophen, as well as many toxicologic and carcinogenic compounds and can be
induced by ethanol and nicotine (Tanaka et al., 2000). In the second stage of the study, when
99 newly collected sibling pairs were added (Schuckit et al., 2005), the peak at 10qter was
significantly diminished. As will be described in this paper, it was initially assumed that the
diminishment was due to locus heterogeneity, but ultimately the reduced evidence for
linkage was explained by a single family with extreme and unreliable phenotypes.
Most of the ethanol that is consumed is oxidized by the liver using alcohol dehydrogenase
(ADH). At the high concentrations associated with chronic alcohol consumption,
metabolism of ethanol to acetaldehyde increases while the subsequent conversion into
acetate is decreased, leading to even higher levels of acetaldehyde. It was shown in rats that
chronic consumption reduced the oxidation of acetaldehyde in the liver, thus providing an
explanation for the high blood acetaldehyde levels measured after chronic use in human
subjects (Lieber, 1999). Acetaldehyde is toxic and highly reactive (Zakhari, 2006), binding
to nearby proteins thus creating an antibody response, decreased DNA repair, and
Webb et al. Page 2













glutathione depletion ultimately reducing the ability of the liver to clear free radicals
(Lieber, 1997). As a result from the oxidation, NAD+ is reduced with the addition of an
electron to form NADH (Zakhari, 2006) used by mitochondria for ATP synthesis. At high
concentrations, ethanol is oxidized by ADH at a higher rate leading to an increase in the
NADH/NAD+ ratio (Zakhari, 2006).
CYP2E1 is part of the Microsomal Ethanol Oxidizing System (MEOS) accounting for up to
10% of ethanol oxidation in the liver (Tanaka et al., 2000). Once the ADH pathway becomes
saturated due to high ethanol concentrations, the MEOS pathway activity increases (Lieber,
1997). By the MEOS pathway, CYP2E1 metabolizes ethanol and other substrates into toxic
metabolites creating free radicals in the form of reactive oxygen (O2) intermediates creating
oxidative stress leading to liver damage. CYP2E1 uses O2 to oxidize ethanol to aldehyde
and NADPH to NADP+. While generally used biosynthetically, NADPH can be regenerated
from NADP+ with the conversion of NADH to NAD+. In the absence of NADPH, oxidation
of ethanol to aldehyde by CYP2E1 results in superoxides (Zakhari, 2006). An excess of
reduced NADH in addition to the increased activity of hydrogen shuttles in mitochondria,
results in an increased intake of electrons leading to an increase of superoxide anions (Seitz
and Stickel, 2007). The increased creation of Reactive Oxygen Species, or ROS, as a result
from the shift in cellular redox state, coupled with the reduced ability to clear these free
radicals, due to the increase in acetaldehyde, is thought to be a major driving force in the
development of alcohol related liver disease.
The catalase pathway can oxidize ethanol in conjunction with hydrogen peroxide generating
systems, such as NADPH oxidase (Zakhari, 2006). The catalase pathways plays a larger
roles in the oxidation of ethanol in the brain, where little ADH oxidation occurs (Zakhari,
2006). In a study by Vasiliou et al. (2006), it was found that animals with a knockout of
either catalase or CYP2E1 were more sensitive to the sedative effects of ethanol than
control, wild-type animals. The study found that CYP2E1 did not contribute significantly to
ethanol clearance in the brain, but was instead involved with ethanol processing in the brain
affecting sensitivity.
High ethanol concentrations can interfere with the ability of CYP2E1 to metabolize other
substrates due to competition from the shared oxidation pathway leading to reduced drug
clearance and elevated drug concentrations (Tanaka et al., 2000). The interaction of certain
drugs with alcohol will lead to a long-lasting, enhanced drug effect, often leading to
overdose. A similar relationship is thought to exist with nicotine. It has been shown that
smokers have a more rapid ethanol clearance than non-smokers, suggesting a biological
basis for the correlation of tobacco and alcohol consumption seen in alcoholics (Schoedel
and Tyndale, 2003).
A number of polymorphisms in CYP2E1 have been tested in relation to alcoholism and a
number of related disorders, including many types of cancer, with varying, often conflicting,
results. Carriers of the c2 allele of CYP2E1*5B have increased risk for alcoholic liver
disease and are more likely to consume excessive amounts of alcohol possibly due to the
higher transcriptional levels of CYP2E1 seen with this allele (Grove et al., 1998;
Pirmohamed et al., 1995; Watanabe et al., 1994). Variants in the gene have been implicated
in the increased risk of different types of cancer relating to the respiratory and digestive
systems (Bouchardy et al., 2000; Liu et al., 2001; Yu et al., 1995).
Due to the previously described relationship between CYP2E1 and the metabolism of
ethanol and positive linkage results concerning the level of response to alcohol in relation to
alcoholism, a number of single nucleotide polymorphisms (SNP) were genotyped in the
CYP2E1 to further elucidate the gene’s role in alcohol response. Both genotype and copy
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number were tested for association with the level of response to alcohol as measured by the
SHAS questionnaire. Combined linkage and association analysis was performed to




The data collection protocol was approved by the Human Subjects Protection Committee at
the University of California in San Diego and used written, informed consent. The design
for the alcohol challenge is fully described in the initial report by Wilhelmsen et al. (2003).
Male and female subjects ranging in age from 18 to 29 years old were recruited from a
population of college students. Chosen sibling pairs reported having an alcohol dependent
parent, but were not alcohol dependent themselves. The siblings included 43.7% males and
56.3% females. They had an average age of 22.4 years and 14.2 years of education. 72.2%
were Caucasian, 20.0% were Hispanic, and 7.8% were African-American. For 85.0% of the
subjects, the alcohol-dependent parent was the father, whereas for 4.4% it was the mother, in
4.0% it was both parents, and in 6.6% the more intensive interview revealed that neither
parent met full criteria for dependence.
To measure each participant’s response to alcohol, the Subjective High Assessment Scale
(SHAS) questionnaire was administered. For the challenge, each subject was given 8
minutes to consume a 20% by volume solution of 95% ethanol, at 0.75 ml/kg for women
and 0.9 ml/kg for men. Baseline levels for each score (SHAS, body sway, and breath alcohol
level) were measured prior to the challenge and then were measured at multiple set time
intervals throughout the 3 hour challenge. Ultimately the changes in SHAS score and body
sway at 1 hour after the challenge were used as phenotypes for the genome-wide genetic
analysis. Genotyping was performed on 811 microsatellite markers across the genome.
Taqman Genotyping
Genomic DNA was extracted from whole peripheral blood samples. Genotyping was
performed on 10 SNPs with Taqman genotyping assays with locus specific PCR primers and
fluorescent allele specific probes designed by Applied Biosystems. Standard Taqman
protocol was followed and endpoint amplification intensity was measured by the 7900 ABI
Sequence Detector. The position of the genotyped markers in relation to CYP2E1 can be
found in Figure 1. The HapMap Consortium reported three major haplotypes in the
Caucasian population, as seen in Figure 1, which could be distinguished by the initial two
SNPs that were genotyped. Table 4 lists the names and positions of the genotyped SNPs.
Copy number analysis
The copy number of CYP2E1 was determined for each sample in quadruplicate through the
amplification of both a probe specific to CYP2E1 and a standard probe by real-time PCR
using the standard Gene Dosage protocol provided by Applied Biosystems (Livak and
Schmittgen, 2001). Preliminary amplification showed the two probes used for analysis had
different efficiencies of amplification, which was corrected by a standard dilution curve
added to each plate. The fold increase after n number of cycles was calculated by
(efficiency)n and the ratio of this increase between the target and reference genes provided
copy number. Standard copy number quantification assumes equal amplification
efficiencies, but this is not always a valid assumption. Correcting for even small differences
in amplification efficiencies leads to less variability among the quadruplicate samples and
lowered standard error in overall copy number determination.
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Index cases from the 96 families with the greatest evidence for linkage to the 10q terminal
region were selected for resequencing. Each coding sequence exon was resequenced using
primers from Applied Biosystems using the standard provided procedure.
Linkage allowing for heterogeneity
A map of the positions of the genotyped SNPs relative to the microsatellite markers was
created with Fastlink. Variance component methods were used to recalculate LOD scores
using SOLAR v4.0.7 with the identity by descent provided through pedigree information
and estimating multipoint identity by descent sharing probabilities (Almasy and Blangero,
1998). Variance component linkage analysis uses correlation in the phenotype to partition
out variance between relative pairs into the effects of the genes in the region of interest,
additive genetic effects of other genes, and non-shared environmental variance. To account
for the heterogeneity evident in the dataset, a calculation assuming locus heterogeneity was
made using the HLOD (heterogeneity LOD) score to identify the cause of the lowered peak
at the end of chromosome 10.
Association analysis
Association between SNP marker allele counts and copy number and SHAS scores were
evaluated using a logistic regression model through the SAS statistical package testing for
statistical inferences using a generalization of the standard linear model. Family ID and
marker genotype were used as classification variables and the effects of copy number and
genotype were modeled against the SHAS score. Genotypes were classified based in the
count of the minor frequency allele.
Combined Linkage and Association
Combined linkage and association analysis using SOLAR v4.0.7 was performed to include
identity by state information similar to the approach used by Almasy et al. (1999) where the
variance in the SHAS score that cannot be accounted for by the covariate parameter based
on the number of minor alleles was decomposed into the standard variance components. To
see whether the linkage signal could be explained by the allele effects of a single SNP, each
SNP marker was individually tested by including the number of minor alleles as a covariate.
Polygenic covariate screening was used to calculate the significance level after the inclusion
of any particular SNP and multipoint analysis was used to calculate the multipoint LOD
score for the SHAS score.
By combining linkage and association approaches, a disease loci position can be confined to
a region finer than linkage analysis alone and avoid false positive association results due to
admixture. Assuming the linkage is not over-estimated, if a measured variant is the actual
functional variant affecting the phenotype and no other variants nearby confer any additional
risk, linkage analysis conditional on the genotype of such a variant should provide no
evidence for linkage. However if the suspected variant is in some degree of linkage
disequilibrium with the actual causal variant, the evidence for linkage will be reduced
proportional to the degree of LD.
Results
With a combined map of microsatellite and SNP markers the dataset was reanalyzed, as
described in the original linkage study (Schuckit et al., 2005; Wilhelmsen et al., 2003), using
SOLAR. When divided into the two stages of sample sets from the previous study,
significant linkage was found in stage 1 samples with a peak LOD score of 3.14; however,
when combining the initial 139 sibling pairs with the additional 99 sibling pairs in stage 2,
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the linkage signal lowered to a peak LOD score of 1.61. The LOD score plot can be seen in
Figure 2.
Multipoint linkage analysis allowing for locus heterogeneity was performed for the SHAS
phenotype using microsatellite and SNP data from 10qter. The family specific heterogeneity
score (α) and LOD score was inspected for each family. Most of the families had α scores of
0.99, one family stood out with an α of 0.37 indicating poor support for linkage to the
region. The individual pedigree LOD score for this family alone was −0.97 accounting for
most of the reduction in LOD score seen between stage 1 and stage 2. Based on the level of
alleles shared between siblings in this family, it was expected that these siblings should have
more similar SHAS scores. The sibling pair had a large difference in phenotype despite
having inherited the same chromosome Identical By Descent from both of their parents (IBD
of 2). While one sibling reported a SHAS score of 26.75 (z = 2.147), the other reported a
SHAS score of 4 (z = −0.7161).
Comments from the observers of the study propose phenotyping error as the cause of the
extreme phenotype difference. The more sensitive sibling felt nauseated during the
challenge. This is a common response reported by many subjects, and the SHAS score for
this individual is around the same value reported by other individuals with a similar
response. The other sibling, with SHAS scores indicating they were insensitive to alcohol,
had a blood alcohol level close to the predicted value, indicating that they were
appropriately dosed. This sibling fainted briefly during blood draw. The researchers
involved in testing these subjects take special care to avoid fainting and report that it only
happens 2% of the time. Although the subject woke up quickly and admittedly felt fine, this
fainting spell could have contributed to the low response indicated by a low SHAS score.
Therefore it is likely that the reduction in LOD score by the inclusion of the discordant
family is due to a phenotyping error. While the inclusion of this family has dramatic affect
on the linkage analysis it has a negligible affect on the association analysis. Due to
irregularity from the reported testing, the whole family was removed from analysis. When
the single family was removed, the original LOD score peak was reestablished with the
maximum LOD score for 10qter at 3.40.
SNP genotypes could not be called automatically using the manufacture supplied program
due to copy number differences which affected the allele signal intensities causing samples
to fall between the heterozygous and homozygous genotypes. Genotype calls were made
manually, assuming that the intermediate samples were either AAB or ABB depending on
the location relative to the heterozygote cluster. The best estimate of copy number and
genotype was made by integrating the real-time PCR measured copy number, Taqman
derived genotype and pedigree structure. While the majority of subjects (85%) have 2
copies, 11% had 3 copies, and 4% had 1 copy. A small number (<2%) were considered to
have greater than 3 copies based on real time PCR, but these measurements were not
considered plausible based on Taqman derived genotype and pedigree information.
Logistic regression analysis using a mixed model to control for the relatedness of subjects
within families was used to investigate the association between copy number genotype and
level of response to alcohol. Copy number had little effect on the level of response to
alcohol. The presence of at least one copy of a relatively rare allele for several SNPs is
associated with a more intense response to alcohol. The best evidence for association was
found for the first three markers, which lie near the beginning of the gene near the promoter
region, when considering genotype alone. The SNP rs10776687 showed the greatest
evidence for association with a p value of 0.007 and was able to explain 4.6% of the
variance of the SHAS score phenotype (r2=0.046). In this case, copy number was ignored
and all genotypes were assigned as biallelic. When considering copy number and genotype
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together, none of the markers were significant. Copy number alone (1, 2, or 3) was not
significantly associated. Interestingly, when modeling the effect of genotype and copy
number on the number of cigarettes smoked per day, copy number of CYP2E1 was
associated with this smoking phenotype with an average p value of 0.014. Association p
values for logistic regression analysis are shown in Table 1.
Intuitively we would expect that inclusion of a causal SNP as a covariate would reduce the
residual linkage due to IBD to zero (Almasy et al., 1999), but this is an area of active
research. After each SNP marker was separately tested in the variance component model, it
was found that inclusion of the number of minor alleles of any single SNP was not able to
explain all variation in the SHAS phenotype. When considering the dataset after removing
family 44, the peak LOD score was 3.36. The marker that lowered this LOD score the most
(by 1.21 LOD units) when included as a covariate was rs10776687, the marker located
closest to the linkage peak. Other SNPs lowered the LOD score by lesser amounts, as seen
in the Table 2 below. Combined linkage and association analysis indicates that no single
locus tested is likely to be the only causal allele. When testing haplotypes, none of the three
haplotypes were able to completely account for the linkage signal.
In addition to testing SNP markers to determine whether a single SNP could directly
influence the SHAS phenotype, a number of smoking and drinking phenotypes were
analyzed by including them as covariates when modeling their relationship with SHAS.
Three of these phenotypes (average number of cigarettes per day, the maximum amount
drank in one day, and the average number of drinks consumed on days the subject consumed
alcohol) improved the overall peak LOD score compared to the model without covariates.
The other tested phenotypes (number of days the subject drank in the last week, amount
consumed 24 hours prior to challenge, number of days of smoking in a month, and number
of cigarettes smoked on days where the subject smoked), lowered the peak LOD score
presumably because these phenotypes are correlated with the SHAS score. All LOD scores
are shown in the Table 3 below.
To examine whether previously unidentified missense sequence changes could be
responsible for the association detected, coding sequence exons were resequenced for 96
index cases from the families with the strongest evidence of linkage. No missense changes
were found and no novel polymorphisms were identified.
Discussion
Alcoholism is a complex disease with potentially many genetic influences. Investigators
have tried to minimize heterogeneity by choosing a narrowly defined phenotype such as the
level of response to alcohol that was measured with the SHAS score in this study.
Significant evidence for linkage to 10qter was observed for the SHAS score in subjects from
an alcohol challenge only after the removal of one family that retrospectively should not
have been included in the analysis. After linkage was found at the end of chromosome 10,
several SNPs genotyped in CYP2E1 were associated through logistic regression with the
level of response to alcohol as reported by the SHAS score. Copy number did not appear to
affect the SHAS score even though copy number differences were found between
individuals across the CYP2E1 gene.
When considered separately, linkage was found over the region containing CYP2E1 and
SNPs from the gene were found to be associated with the SHAS score. If inclusion of the
causal variant as a covariate in variance component analysis always reduces the residual
LOD score to zero, we were unable to implicate a causal variant directly influencing the
level of response to alcohol in the families studied. It is possible that an unidentified
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polymorphism nearby could play a causal role in the level of response to alcohol as the
degree of signal reduction is largest in the marker closest to the linkage peak and then
declines for markers farther away. Another possibility is that a single marker cannot account
for the entire linkage signal because many markers in the region play a role in the response.
Instead of a single polymorphism causing variation, combinations of polymorphisms across
the region may work together to contribute to the variation seen in our dataset. Support from
the heterogeneity LOD score calculation showing that all families showed evidence for
linkage combined with the independently derived association analysis imply that the LOD
score peak was not over-estimated. It still can be concluded the regulatory sequences near
CYP2E1 appear to play a role in the level of response to alcohol.
Variance component linkage analysis for the level of response to alcohol was significantly
affected by including covariates for recent drinking and smoking behavior. Since CYP2E1
expression is inducible by alcohol and nicotine (Joshi and Tyndale, 2006), this further
supports the role of CYP2E1 in level of response to alcohol. CYP2E1 represents a metabolic
intersection between these substances of abuse (Schoedel and Tyndale, 2003). It was
initially surprising that while an association was not found between the level of response to
alcohol and copy number of CYP2E1, an association was found between nicotine use and
copy number. Studies have shown that neither ethanol nor nicotine increase the level of
CYP2E1 mRNA in rat hepatic tissue (Howard et al., 2001). Ethanol likely changes the
activity of CYP2E1 by interacting with the active site leading to increased protein
stabilization and reduced clearance by degradation. Given the induction of CYP2E1 by
nicotine requires multiple doses and does not interact with the catalytic function of CYP2E1,
it is thought that the mechanism behind nicotine induction is not through protein
stabilization. (Micu et al., 2003; Schoedel and Tyndale, 2003) Since the molar
concentrations are vastly different it is unlikely that both nicotine and alcohol could stabilize
CYP2E1 by the same mechanism. Since ethanol and nicotine likely induce CYP2E1 through
different mechanisms, these two drugs may have an additive effect on CYP2E1 induction
and function (Schoedel and Tyndale, 2003). The ability to induce CYP2E1 activity by
nicotine, but not alcohol, could be dependent on basal transcription rates that could be
affected by gene copy number.
The four polymorphisms commonly tested in CYP2E1, CYP2E1*5B (c2), CYP2E1*6 (C),
CYP2E1*1B (A1), and CYP2E1*1D (1C), have been found to be associated with
alcoholism and related disorders in a number of studies. Several of these variants are rare in
the Caucasian population (see below). Carriers of the c2 allele of *5B have often been found
to have increased risk for alcoholic liver disease (Grove et al., 1998) possibly due to the
increased tendency to consume excessive amounts of alcohol (Pirmohamed et al., 1995).
The C allele of *6 was shown to be associated with the predisposition for alcoholism in
Japanese men (Iwahashi et al., 1998). The A1 allele of *1B was found to have a significantly
higher allele frequency in alcoholics than in nonalcoholic individuals from a Mexican
Indians population (Montano Loza et al., 2006). The 1D variant allele was shown to be
associated with elevated CYP2E1 activity after alcohol consumption (McCarver et al.,
1998). For every association found with CYP2E1 variants, a number of studies found no
association between the variants and alcohol consumption or risk of alcoholism which could
be due to differing phenotype categorization or population allele frequencies (Carr et al.,
1996; Itoga et al., 2001; Pastorelli et al., 2001; Plee-Gautier et al., 2001; Vidal et al., 2004).
Of the markers measured in the current study, the most associated SNP with level of
response to alcohol, rs10776687, is in complete linkage disequilibrium (LD) with the c1
allele of CYP2E1*5B, rs2031920, implying that this marker is associated with the level of
response to alcohol as well. A homozygous genotype of the minor allele c2 of CYP2E1*5B
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is associated with an increase in gene transcription (Watanabe et al., 1994). Another marker,
rs2515641, is in complete LD with rs2070676, also known as CYP2E1*1B.
As CYP2E1 is involved with the metabolism of many carcinogenic compounds, it is not
surprising that variants in the gene have been implicated in a number of different types of
cancer. The generation of ROS as a result of CYP2E1 oxidation will lead to the creation of
lipid peroxidation products such as 4-hydroxynonenal which reacts with DNA to form DNA
adducts leading to highly mutagenic cells resistant to apoptosis (Carr et al., 1996). The
metabolism of procarcinogens by CYP2E1 commonly found in alcohol, tobacco, and
industrial chemicals can be enhanced through chronic ethanol (Bailey and Cunningham,
2002).
While a number of CYP2E1 variants have been analyzed in relation to cancer development,
CYP2E1*5B is most often considered. Many of these associations are enhanced by alcohol
or nicotine intake which further supports the role of CYP2E1 in the metabolism of these
substances. The c1/c1 genotype of the CYP2E1*5B variant increased risk of hepatocellular
carcinoma in smokers from a Taiwanese population (Yu et al., 1995) and oral cavity cancer
in heavy smokers from Caucasians and African Americans populations (Liu et al., 2001).
Conversely other studies have found evidence for the minor c2 allele leading to an increased
risk of hepatocellular carcinoma in ethanol users with chronic liver disease and oral cavity
cancer in combination with heavy drinking (Bouchardy et al., 2000). Others have found no
association between the CYP2E1*5B variant and the same types of cancer including a
number of studies for hepatocellular carcinoma (Kato et al., 1995; Lee et al., 1997; Wong et
al., 2000). Many CYP2E1 association studies did not detect an association because the c2
risk allele is rare in Caucasians (2–3%) (Kato et al., 1992; Pastorelli et al., 2001) and
African Americans (0.3–7%) (Kato et al., 1992; London et al., 1996; Wu et al., 1997), but
much more common for Asian (24–30%) (Lee et al., 1997; Tan et al., 2000; Watanabe et al.,
1990) and Mexican American populations (15%) (Wu et al., 1997).
In aggregate it appears that alleles that increase CYP2E1 expression increase level of
response to alcohol and risk for cancer, presumably by allowing the activation of
procarcinogens or the production of ROS. Previous evidence for the involvement of
CYP2E1 with alcohol metabolism and the incidence of several alcohol related cancers,
strongly supports the conclusion that CYP2E1 alleles are associated with the level of
response to alcohol and ultimately the development of alcohol use disorders. With multiple
lines of evidence linking CYP2E1 to alcohol intake and subsequent outcomes, this gene can
be an important predictor of risk for alcoholism and provide us with a better understanding
of how the brain perceives alcohol. Drugs that affect the expression of this gene and,
subsequently, the perception of alcohol, could reduce intoxication or limit consumption and
thus moderate the development of alcoholism.
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Figure 1. Location of genotyped SNPs in relation to CYP2E1 on chromosome 10
Figure 1 The top of the figure shows the position on chromosome 10 with each SNP location
indicated by triangles. The middle part of the figure shows the position of CYP2E1 with
exons represented as yellow rectangles and introns as the lines between. At the bottom,
phased haplotypes derived from the HapMap Caucasian (CEU) population are shown. Each
vertical block represents a SNP genotyped in HapMap. Not all of these markers were
genotyped in the study, so vertical black lines through the haplotype figure indicate actual
genotyped SNPs.
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Figure 2. LOD score plot showing linkage in the region surrounding CYP2E1
Figure 2 Shows the LOD score plot highlighting the linkage near CYP2E1. The line labeled
as First Set represents the initial 139 sibling pairs. The line labeled as Second Set represents
the complete set of 238 sibling pairs. Once the family with questionable phenotypes was
removed, the strength of the linkage signal was restored to the level provided by the First Set
samples. Locations of microsatellite markers and SNPs are shown on the X-axis.
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Table 1
Association p values for logistic regression analysis between the SHAS score and CYP2E1
genotype alone or genotype considering copy number
Logistic regression was used to test for association between the genotyped SNPs and the SHAS quantity
representing the level of response to alcohol. P-values < 0.05 are in bold. The three markers near the 3’ end
and two from the 5’ end were most associated with the level of response to alcohol. The best evidence for
association came from the initial SNP, rs10776687. None of the SNPs were associated when the genotype call
was made considering copy number.




rs10776687 0.007 0.103 0.056
rs9418990 0.024 0.125 0.244
rs2070673 0.015 0.077 0.238
hCV30633979 0.215 0.253 0.004
rs943975 0.182 0.274 0.131
rs6413421 0.133 0.123 0.057
rs915909 0.058 0.081 0.007
rs2515641 0.45 0.261 0.176
rs2480258 0.04 0.187 0.252
rs2249695 0.024 0.139 0.268
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Table 2
Results of variance component linkage analysis for combined linkage and association
Combined linkage and association analysis showed that a single marker was unable to account for all of the
variation in the signal. This was accomplished by adding each SNP individually into the model as a covariate.
With no covariates, the LOD score was 3.36. The SNP that lowered the score the most when added as a
covariate was rs10776687and was able to explain 5.3% of the variance in the SHAS score.
Covariate
LOD
score link+assoc covar p Variance
None 3.36
rs10776687 2.15 4.85 4.25E-04 0.0531
rs9418990 2.46 4.13 5.65E-03 0.021
rs2070673 2.54 4.25 5.04E-03 0.0311
rs943975 2.23 2.87 8.74E-02 0.0105
rs2515641 2.88 3.69 5.30E-02 0.0076
rs2480258 2.42 3.77 1.26E-02 0.0268
rs2249695 2.54 3.99 9.58E-03 0.02
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Table 3
Results of variance component linkage analysis with the inclusion of several drinking and
smoking covariates
A number of smoking and drinking phenotypes were analyzed by including them as covariates when modeling
their relationship with SHAS. Three of these phenotypes (average number of cigarettes per day, the maximum
amount drank in one day, and the average number of drinks consumed on days the subject drank) improved






number of days in the last week where subject drank 2.19 5.07 0.078
amount consumed in the last 24 hours 2.82 3.68 0.028
days smoking per month in previous 6 months 3.03 4.81 0.046
cigarettes per day, on smoking days in previous 6 months 3.27 4.95 0.036
Average number of cigarettes per day 3.37 4.49 0.026
maximum amount drank in one day 3.47 6.92 0.084
Average number of drink on days they drank 3.77 6.24 0.066
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Table 4
Translation of identification values for genotyped SNPs and position
A listing of the various identification names for the SNPs genotyped in the study based on the Applied
Biosystems ID. Included under “other names” are names commonly used for specific markers.






rs2070673 hCV2431871 135190557 CYP2E1*7_-333T>A
-- hCV30633979 135192024 CYP2E1*2,g.1132G>A
rs943975 hCV7468406 135192250
rs6413421 hCV25594214 135195801
rs915909 hCV7468401 135197387 CYP2E1_6498C>T(I321I)
rs2515641 hCV16026002 135201352 CYP2E1_10463T>C(F421F)
rs2480258 hCV2431850 135202090
rs2249695 hCV2431848 135202158
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